|Articles|April 12, 2016
OmniComm Penetrates Growing Israeli Life Sciences Market
OmniComm has announced the signing of an agreement with Medistat Ltd.
Advertisement
OmniComm has announced the signing of an agreement with Medistat Ltd., headquartered in Tel Aviv, Israel; to address the clinical trial needs of the growing Israeli life sciences sector. Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
2
ACT Brief: Decentralized Innovation Faces Reality, RWE Finds Its Lane, and Clinical Ops Reset for 2026
3
ESG as a Quality System: Practical Steps to Embed Sustainability Into Vendor Oversight
4
Operational and Governance Barriers to Regulatory-Grade RWE
5